Variants in Mitochondrial ATP Synthase Cause Variable Neurologic Phenotypes
Name:
Annals of Neurology - 2022 - ...
Size:
1.576Mb
Format:
PDF
Description:
Final Published Version
Author
Zech, MichaelKopajtich, Robert
Steinbrücker, Katja
Bris, Céline
Gueguen, Naig
Feichtinger, René G
Achleitner, Melanie T
Duzkale, Neslihan
Périvier, Maximilien
Koch, Johannes
Engelhardt, Harald
Freisinger, Peter
Wagner, Matias
Brunet, Theresa
Berutti, Riccardo
Smirnov, Dmitrii
Navaratnarajah, Tharsini
Rodenburg, Richard J T
Pais, Lynn S
Austin-Tse, Christina
O'Leary, Melanie
Boesch, Sylvia
Jech, Robert
Bakhtiari, Somayeh
Jin, Sheng Chih
Wilbert, Friederike
Kruer, Michael C
Wortmann, Saskia B
Eckenweiler, Matthias
Mayr, Johannes A
Distelmaier, Felix
Steinfeld, Robert
Winkelmann, Juliane
Prokisch, Holger
Affiliation
Departments of Child Health, Neurology, and Cellular & Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine-PhoenixIssue Date
2022-01-20
Metadata
Show full item recordPublisher
John Wiley and Sons IncCitation
Zech, M., Kopajtich, R., Steinbrücker, K., Bris, C., Gueguen, N., Feichtinger, R. G., Achleitner, M. T., Duzkale, N., Périvier, M., Koch, J., Engelhardt, H., Freisinger, P., Wagner, M., Brunet, T., Berutti, R., Smirnov, D., Navaratnarajah, T., Rodenburg, R. J. T., Pais, L. S., … Prokisch, H. (2021). Variants in Mitochondrial ATP Synthase Cause Variable Neurologic Phenotypes. Annals of Neurology.Journal
Annals of neurologyRights
© 2021 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Objective: ATP synthase (ATPase) is responsible for the majority of ATP production. Nevertheless, disease phenotypes associated with mutations in ATPase subunits are extremely rare. We aimed at expanding the spectrum of ATPase-related diseases. Methods: Whole-exome sequencing in cohorts with 2,962 patients diagnosed with mitochondrial disease and/or dystonia and international collaboration were used to identify deleterious variants in ATPase-encoding genes. Findings were complemented by transcriptional and proteomic profiling of patient fibroblasts. ATPase integrity and activity were assayed using cells and tissues from 5 patients. Results: We present 10 total individuals with biallelic or de novo monoallelic variants in nuclear ATPase subunit genes. Three unrelated patients showed the same homozygous missense ATP5F1E mutation (including one published case). An intronic splice-disrupting alteration in compound heterozygosity with a nonsense variant in ATP5PO was found in one patient. Three patients had de novo heterozygous missense variants in ATP5F1A, whereas another 3 were heterozygous for ATP5MC3 de novo missense changes. Bioinformatics methods and populational data supported the variants’ pathogenicity. Immunohistochemistry, proteomics, and/or immunoblotting revealed significantly reduced ATPase amounts in association to ATP5F1E and ATP5PO mutations. Diminished activity and/or defective assembly of ATPase was demonstrated by enzymatic assays and/or immunoblotting in patient samples bearing ATP5F1A-p.Arg207His, ATP5MC3-p.Gly79Val, and ATP5MC3-p.Asn106Lys. The associated clinical profiles were heterogeneous, ranging from hypotonia with spontaneous resolution (1/10) to epilepsy with early death (1/10) or variable persistent abnormalities, including movement disorders, developmental delay, intellectual disability, hyperlactatemia, and other neurologic and systemic features. Although potentially reflecting an ascertainment bias, dystonia was common (7/10). Interpretation: Our results establish evidence for a previously unrecognized role of ATPase nuclear-gene defects in phenotypes characterized by neurodevelopmental and neurodegenerative features.Note
Open access articleISSN
0364-5134EISSN
1531-8249PubMed ID
34954817Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1002/ana.26293
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2021 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License.